354 related articles for article (PubMed ID: 17056461)
1. A new procedure for experimental autoimmune uveitis with small uveitogenic peptides.
Sery TW; Su YH; Eagle R; Ueda M; Yamamoto N
Ocul Immunol Inflamm; 2006 Oct; 14(5):277-83. PubMed ID: 17056461
[TBL] [Abstract][Full Text] [Related]
2. Xenopus IRBP, a phylogenetically remote protein, is uveitogenic in Lewis rats.
Gelderman MP; Gonzalez-Fernandez F; Baer CA; Wiggert B; Chan CC; Vistica BP; Gery I
Exp Eye Res; 2000 Jun; 70(6):731-6. PubMed ID: 10843777
[TBL] [Abstract][Full Text] [Related]
3. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein.
Kotake S; de Smet MD; Wiggert B; Redmond TM; Chader GJ; Gery I
J Immunol; 1991 May; 146(9):2995-3001. PubMed ID: 1707928
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
6. [Experimental autoimmune uveoretinitis and pinealitis in Lewis rats induced by varied doses of interphotoreceptor retinoid-binding protein].
Yang PZ
Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):373-6. PubMed ID: 8020385
[TBL] [Abstract][Full Text] [Related]
7. Uveitogenic potential of lymphocytes sensitized to interphotoreceptor retinoid-binding protein.
McAllister CG; Wiggert B; Chader GJ; Kuwabara T; Gery I
J Immunol; 1987 Mar; 138(5):1416-20. PubMed ID: 3805723
[TBL] [Abstract][Full Text] [Related]
8. Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.
Donoso LA; Merryman CF; Sery T; Sanders R; Vrabec T; Fong SL
J Immunol; 1989 Jul; 143(1):79-83. PubMed ID: 2786534
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides.
Sasamoto Y; Kawano YI; Bouligny R; Wiggert B; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2641-9. PubMed ID: 1639611
[TBL] [Abstract][Full Text] [Related]
10. A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.
Boldison J; Khera TK; Copland DA; Stimpson ML; Crawford GL; Dick AD; Nicholson LB
Immunology; 2015 Oct; 146(2):301-11. PubMed ID: 26152845
[TBL] [Abstract][Full Text] [Related]
11. Stimulation in vitro of lymphocytes for induction of uveoretinitis without any significant proliferation.
Kotake S; Wiggert B; Zhang XY; Redmond TM; Chader GJ; Gery I
J Immunol; 1990 Jul; 145(2):534-9. PubMed ID: 1694880
[TBL] [Abstract][Full Text] [Related]
12. Unusual immunologic properties of the uveitogenic interphotoreceptor retinoid-binding protein-derived peptide R23.
Kotake S; Redmond TM; Wiggert B; Vistica B; Sanui H; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2058-64. PubMed ID: 2055698
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein.
Hara Y; Caspi RR; Wiggert B; Chan CC; Wilbanks GA; Streilein JW
J Immunol; 1992 Mar; 148(6):1685-92. PubMed ID: 1531843
[TBL] [Abstract][Full Text] [Related]
14. Identification of a uveitogenic cyanogen bromide peptide of bovine retinal S-antigen and preparation of a uveitogenic, peptide-specific T cell line.
Gregerson DS; Obritsch WF; Fling SP
Eur J Immunol; 1987 Mar; 17(3):405-11. PubMed ID: 3494613
[TBL] [Abstract][Full Text] [Related]
15. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
MartÃn AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
[TBL] [Abstract][Full Text] [Related]
16. Analysis of uveitogenic sites in phosducin molecule.
Satoh N; Abe T; Nakajima A; Ohkoshi M; Koizumi T; Tamada H; Sakuragi S
Curr Eye Res; 1998 Jul; 17(7):677-86. PubMed ID: 9678412
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a potent uveitopathogenic site derived from rat phosducin.
Abe T; Satoh N; Nakajima A; Koizumi T; Tamada M; Sakuragi S
Exp Eye Res; 1997 Nov; 65(5):703-10. PubMed ID: 9367650
[TBL] [Abstract][Full Text] [Related]
18. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
19. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
Sunil S; Eto K; Singh VK; Shinohara T
Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
[TBL] [Abstract][Full Text] [Related]
20. Serial adoptive transfer of experimental autoimmune uveoretinitis in rats.
Hu LH; Sanui H; Wiggert B; Redmond TM; Chan CC; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1409-12. PubMed ID: 2365573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
